Fine-needle aspiration biopsy diagnosis of histiocyte-rich rhabdomyoblastic tumor (inflammatory leiomyosarcoma): A case report

被引:0
作者
McHugh, Kelsey E. [1 ,2 ]
Kilpatrick, Scott E. [1 ]
机构
[1] Cleveland Clin, Dept Anat Pathol, Cleveland, OH USA
[2] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, 9500 Euclid Ave,L25, Cleveland, OH 44195 USA
关键词
aspiration biopsy; cytology; leiomyosarcoma; muscle neoplasm; GENE-EXPRESSION;
D O I
10.1002/dc.25086
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Histiocyte-rich rhabdomyoblastic tumor (HRRMT) is an exceedingly rare soft tissue tumor of primitive myogenic differentiation. We report herein a case involving the soft tissue in the left lateral peri-scapular region in a 68-year-old female with a 2-month history of a non-painful soft tissue mass. Ultrasound revealed a solid, ovoid subcutaneous mass lesion that lacked significant internal vascularity. Percutaneous fine-needle aspiration (FNA) biopsy with concomitant core needle biopsy was performed, and a diagnosis of HRRMT was rendered. Cytologic smears were hypercellular, composed of a mixture of foamy histiocytes and a variably cohesive population of epithelioid and plasmacytoid to vaguely spindled cells in cohesive clusters and singly dispersed. Histologic material showed sheets of epithelioid and plasmacytoid to spindled cells with admixed foamy histiocytes with distended, vacuolated cytoplasm. To our knowledge, this is the first reported example of HRRMT evaluated by FNA biopsy.
引用
收藏
页码:E109 / E112
页数:4
相关论文
共 14 条
[1]   Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature [J].
Arbajian, Elsa ;
Koster, Jan ;
von Steyern, Fredrik Vult ;
Mertens, Fredrik .
MODERN PATHOLOGY, 2018, 31 (01) :93-100
[2]   NEAR-HAPLOIDY IN 2 MALIGNANT FIBROUS HISTIOCYTOMAS [J].
ASPBERG, F ;
MERTENS, F ;
BAUER, HCF ;
LINDHOLM, J ;
MITELMAN, F ;
MANDAHL, N .
CANCER GENETICS AND CYTOGENETICS, 1995, 79 (02) :119-122
[3]   Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnoses [J].
Bourgeau, Melanine ;
Martinez, Anthony P. .
VIRCHOWS ARCHIV, 2021, 478 (02) :367-373
[4]   So-called "Inflammatory leiomyosarcoma": A series of 3 cases providing additional insights into a rare entity [J].
Chang, A ;
Schuetze, SM ;
Conrad, EU ;
Swisshelm, KL ;
Norwood, TH ;
Rubin, BP .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2005, 13 (02) :185-195
[5]   "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor" [J].
Cloutier, Jeffrey M. ;
Charville, Gregory W. ;
Mertens, Fredrik ;
Sukov, William ;
Fritchie, Karen ;
Perry, Kyle D. ;
Edgar, Mark ;
Rowsey, Ross A. ;
Folpe, Andrew L. .
MODERN PATHOLOGY, 2021, 34 (04) :758-769
[6]  
Dal Cin P, 1998, J PATHOL, V185, P112
[7]  
Fletcher C DM., 2002, WHO classification of tumours editorial board: soft tissue and bone tumours, V3rd
[8]   Inflammatory rhabdomyoblastic tumor with progression to high-grade rhabdomyosarcoma [J].
Geiersbach, Katherine ;
Kleven, Daniel T. ;
Blankenship, Heath T. ;
Fritchie, Karen ;
Folpe, Andrew L. .
MODERN PATHOLOGY, 2021, 34 (05) :1035-1036
[9]   Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms [J].
Martinez, Anthony P. ;
Fritchie, Karen J. ;
Weiss, Sharon W. ;
Agaimy, Abbas ;
Haller, Florian ;
Huang, Hsuan-Ying ;
Lee, Seungjae ;
Bahrami, Armita ;
Folpe, Andrew L. .
MODERN PATHOLOGY, 2019, 32 (03) :446-457
[10]   Inflammatory leiomyosarcoma: A morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma [J].
Merchant, W ;
Calonje, E ;
Fletcher, CDM .
HISTOPATHOLOGY, 1995, 27 (06) :525-532